Please assess the completion status of the following clinical trial:

Trial Title: Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* type 1 diabetes (well controlled, 2-3 hypoglycemic episodes/wk)~* age 18-50~* BMI 18-30~Exclusion Criteria:~* pregnancy~* significant diabetes complications~* liver disease, cirrhosis~* cardiac disease~* neurological disorder~* autonomic neuropathy~* kidney disease~* lactose intolerance

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Type 1 Diabetics (Type: ACTIVE_COMPARATOR): The active group were participants with type 1 diabetes.
- Healthy Volunteers (Type: OTHER): The control group were participants without diabetes, matched by sex, age and BMI to the active comparator group.

Based on this trial design, predict the completion outcome and termination type (if applicable).